Bridging_Genomics基因和健康.pptVIP

Vita Genomics Overview Formed in 2001, capital of $100M USD Focus on diseases prevailed in Asia and using SNP as an approach, aim at personalized medicine Total employees: 140 (Taipei:90, Shanghai:50) PhD : 20 MS : 55 70 % in RD GeneCore Overview GeneCore Distribution Channel in China GeneCore Technology Platform HepaType C / C肝適治型 * GeneCore ~ Your better choice for cooperation Bridging Genomics to Medicine GeneCore GeneCore’s Strategic Bridging Position GeneCore was established in Shanghai Caohejing High-tech Park in 1997. The first foreign-owned company participated in Chinese Human Genome Project. Vita Genomics acquired GeneCore in 2003. GeneCore is providing biotech service with genomics and proteomics. GeneCore’s Strategic Bridging Position Biotech in Taiwan GeneCore in Shanghai Biotech in China Vita USA USA Market China Market Taiwan Market GeneCore Vita CytoPharm Biotech service Expertise in marketing Professional sales force Customer resource Integrated management system GeneCore’s Strategic Bridging Position Headquarters In Shanghai Guangdong Office Beijing Office Hubei Office Customer resource Research Institutes Universities Hospitals Biotech company Pharmaceutical company Over 25 provinces, HONG KONG Taiwan Y Y RNA Proteins Modified Proteins DNA Biological Function Transcription Translation Post-Translation Modification Genome Transcriptome Proteome Solution for Genomics Proteomics DNA Synthesis Proteomics Platform SNP Analysis STR-based Genotyping Bioinformatics Real time PCR analysis DNA Sequencing Genome Data Presentation Functional Data Integration Genome Data Integration Functional Genomics Information Viewer STR SNP Gene Contig Repeat Primer HapMap Genome Information Viewer Genome Browser Others Public Celera NCBI Genome Assembly Celera Genome Assembly GO KEGG PDB Others VITA VITA Database Integr